Mete, O. Et Al. 2010. Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas. VIRCHOWS ARCHIV , vol.456, no.5 , 515-521.

Mete, O., Kapran, Y., Gulluoglu, M., Kilicaslan, I., Erbil, Y., Senyurek, Y., ... Dizdaroglu, F.(2010). Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas. VIRCHOWS ARCHIV , vol.456, no.5, 515-521.

Mete, Oezguer Et Al. "Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas," VIRCHOWS ARCHIV , vol.456, no.5, 515-521, 2010

Mete, Oezguer Et Al. "Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas." VIRCHOWS ARCHIV , vol.456, no.5, pp.515-521, 2010

Mete, O. Et Al. (2010) . "Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas." VIRCHOWS ARCHIV , vol.456, no.5, pp.515-521.

@article{article, author={Oezguer Mete Et Al. }, title={Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas}, journal={VIRCHOWS ARCHIV}, year=2010, pages={515-521} }